LOGIN
Botulinum Toxin A Vs Platelet-Rich Plasma Vs Control for Chronic Plantar Fasciitis
May 2024
Botulinum Toxin A Vs Platelet-Rich Plasma Vs Control for Chronic Plantar Fasciitis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Botulinum toxin A versus platelet rich plasma ultrasound-guided injection in the treatment of plantar fasciitis: A randomised controlled trial.
Foot Ankle Surg . 2024 Feb;30(2):117-122.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
64 patients with plantar fasciitis were randomized to receive ultrasound-guided injections of Botulinum toxin A (BTX-A; n=22) or Platelet Rich Plasma (PRP; n=23) or to undergo conservative stretching-based treatment (control; n=19). Outcomes of interest were pain relief measured by the Visual Analogue Scale (VAS), functional recovery assessed by the American Orthopaedic Foot and Ankle Society (AOF...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.